alcoholic neuropathy: A condition where damage to the peripheral nervous system (including the peripheral elements of the autonomic nervous system) is associated with chronic ingestion of alcoholic beverages. The disorder may be caused by a direct effect of alcohol, an associated nutritional deficiency, or a combination of factors. Clinical manifestations include variable degrees of weakness; ATROPHY; PARESTHESIAS; pain; loss of reflexes; sensory loss; diaphoresis; and postural hypotension. (From Arch Neurol 1995;52(1):45-51; Adams et al., Principles of Neurology, 6th ed, p1146)
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
345 |
4. Check minimum number of eventsNone |
345 |
5. Include endpointsNone |
345 |
6. Filter based on genotype QC (FinnGen only) |
345 |
Control definitions (FinnGen only)
- Control exclude
- G6_POLYNEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G62
- Name in latin
- Polyneuropathia alcoholica
Similar endpoints
↥List of similar endpoints to
Alcohol induced polyneuropathy
based on the number of shared cases.
Similar with more cases:
- Polyneuropathies and other disorders of the peripheral nervous system
- Alcohol use disorder, Swedish definition
- Alcohol related diseases, tilastokeskus definition
- Alcohol related diseases and deaths, all endpoints
- Neurological diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4609 | 835 | 3665 |
| Only index persons | 3095 | 628 | 2467 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.02 | 0.10 |
| Only index persons | 0.08 | 0.02 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 57.12 | 56.02 | 57.32 |
| Only index persons | 57.57 | 57.05 | 57.70 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 345 | 68 | 277 |
| Unadjusted period prevalence (%) | 0.10 | 0.02 | 0.12 |
| Median age at first event (years) | 58.20 | 55.50 | 58.86 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 303
- Matched controls
- 3030
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G62.1
ICD-10 Finland
Alcoholic polyneuropathy
4503599627370496.0
323.0
278
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
29.8
109.7
156
104
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
107.6
86.0
91
12
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
124.2
57.2
60
6
F10.25
ICD-10 Finland
Alcohol dependence continuous use
42.6
54.2
67
20
F10.20
ICD-10 Finland
Alcohol dependence currently independent
30.9
50.8
68
28
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
24.0
47.2
68
36
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
35.5
45.1
58
20
F10.24
ICD-10 Finland
Alcohol depence active use
42.6
35.8
44
12
P15
ICPC
Chronic alcohol abuse
18.5
34.6
54
35
N07BB01
ATC
disulfiram; oral
10.8
30.5
61
69
3575A
ICD-9 Finland
Inflammatory and toxic neuropathy, Alcoholic polyneuropathy
+∞
29.7
28
*
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
19.1
28.1
43
26
N05CD07
ATC
temazepam; oral
5.6
27.3
90
213
N05BA02
ATC
chlordiazepoxide; systemic
13.4
25.5
45
39
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.9
25.2
139
542
N05AH04
ATC
quetiapine; oral
5.1
25.2
91
236
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
24.6
25.0
35
16
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
23.8
24.1
34
16
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
15.4
22.5
37
27
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
31.9
22.3
29
10
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
17.0
22.1
35
23
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.4
22.1
93
278
R56.8
ICD-10 Finland
Other and unspecified convulsions
9.2
22.0
47
59
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
18.4
21.5
33
20
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.8
21.2
64
133
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.5
20.9
131
547
N05CF01
ATC
zopiclone; oral
3.3
20.5
139
612
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
33.9
19.6
25
8
N06AX11
ATC
mirtazapine; oral
3.3
19.5
127
538
N06AB04
ATC
citalopram; systemic
3.7
19.1
98
343
N05BA04
ATC
oxazepam; oral
3.5
18.7
107
409
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.3
18.6
120
500
K70.1
ICD-10 Finland
Alcoholic hepatitis
27.1
18.5
25
10
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
21.7
18.1
26
13
N03AX12
ATC
gabapentin; oral
4.3
18.1
73
206
F10.09
ICD-10 Finland
Alcohol intoxication UNS
13.1
17.8
31
26
AA1AD
NOMESCO Finland
CT of head and brain
3.3
17.3
109
442
C03DA01
ATC
spironolactone; oral
4.6
16.9
63
163
A06AD11
ATC
lactulose; oral
3.7
16.4
82
278
T36
ICD-10 Finland
Poisoning by systemic antibiotics
8.8
15.8
34
43
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.9
15.6
71
221
N05AA02
ATC
levomepromazine; systemic
7.5
15.6
37
55
C03CA01
ATC
furosemide; systemic
2.9
15.4
124
586
R53
ICD-10 Finland
Malaise and fatigue
3.3
14.9
85
316
E87.6
ICD-10 Finland
Hypokalaemia
10.9
14.8
28
28
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
14.7
70
226
K70.4
ICD-10 Finland
Alcoholic hepatic failure
38.1
14.6
18
5
P16
ICPC
Acute alcohol abuse
13.6
14.2
24
19
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
18.7
14.0
21
12
A28
ICPC
Limited function/disability NOS
3.5
14.0
74
257
L28
ICPC
Limited function/disability (L)
3.4
13.6
73
257
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
22.4
13.5
19
9
D64.9
ICD-10 Finland
Anaemia, unspecified
3.8
13.5
61
188
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
13.9
13.1
22
17
K70.0
ICD-10 Finland
Alcoholic fatty liver
29.9
13.1
17
6
W19
ICD-10 Finland
Unspecified fall
4.3
13.1
51
137
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
52.4
13.0
15
*
K92.0
ICD-10 Finland
Haematemesis
7.6
12.9
30
43
N05BA01
ATC
diazepam; systemic, rectal
3.5
12.9
67
230
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
8.9
12.9
27
33
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
18.3
12.7
19
11
Z72.1
ICD-10 Finland
Alcohol use
21.2
12.6
18
9
G62.8
ICD-10 Finland
Other specified polyneuropathies
135.4
12.5
13
*
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
135.4
12.5
13
*
S72.0
ICD-10 Finland
Fracture of neck of femur
6.6
12.5
32
53
XF400
NOMESCO Finland
ECG with 12 standard connections
3.0
12.0
78
313
A46
ICD-10 Finland
Erysipelas
3.1
11.9
71
269
N06AB03
ATC
fluoxetine; oral
3.8
11.8
53
162
N06AB10
ATC
escitalopram; oral
3.0
11.6
74
291
S42.2
ICD-10 Finland
Fracture of upper end of humerus
7.6
11.3
26
37
N03AF01
ATC
carbamazepine; oral, rectal
5.3
11.1
34
71
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
12.6
11.0
19
16
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
11.0
56
189
V03AA01
ATC
NA
9.0
10.7
22
26
K85
ICD-10 Finland
Acute pancreatitis
11.8
10.7
19
17
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
6.2
10.6
28
49
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.5
10.5
96
467
S01.0
ICD-10 Finland
Open wound of scalp
4.0
10.5
42
116
N03AX16
ATC
pregabalin; oral
2.5
10.4
94
456
SPAT1265
SPAT
Breathalyser
19.6
10.4
15
8
N02AX02
ATC
tramadol; systemic, rectal
2.2
10.3
159
1003
N05AB01
ATC
dixyrazine; systemic
11.9
10.2
18
16
N06AA09
ATC
amitriptyline; systemic
3.7
10.0
44
132
S22.3
ICD-10 Finland
Fracture of rib
3.9
9.5
39
110
X59
ICD-10 Finland
Exposure to unspecified factor
2.7
9.2
71
312
R18
ICD-10 Finland
Ascites
8.7
9.2
19
23
L89
ICD-10 Finland
Decubitus ulcer and pressure area
12.0
9.2
16
14
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
6.9
9.1
22
34
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.1
9.1
35
93
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.7
9.1
40
120
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.7
9.0
30
69
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
24.9
9.0
12
5
N05AD03
ATC
melperone; systemic
13.1
9.0
15
12
N06AX16
ATC
venlafaxine; oral
3.2
8.9
49
172
R60.0
ICD-10 Finland
Localized oedema
3.2
8.9
47
163
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.3
8.8
32
81
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.0
8.7
27
58
A02BC01
ATC
omeprazole; systemic
2.3
8.7
97
518
F34.1
ICD-10 Finland
Dysthymia
6.3
8.6
22
37
IAB10
NOMESCO Finland
Psychiatric consultation concerning substance abuse
+∞
8.4
8
*
C07AA05
ATC
propranolol; systemic
2.6
8.3
63
274
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.1
8.3
47
171
TKC20
NOMESCO Finland
Catheterisation of bladder
3.3
8.2
42
142
N05BE01
ATC
buspirone; oral
6.9
8.0
19
29
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
5.3
7.9
23
46
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.7
7.8
33
96
G63.2
ICD-10 Finland
Diabetic polyneuropathy
46.2
7.8
9
*
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
46.2
7.8
9
*
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
46.2
7.8
9
*
N02AA05
ATC
oxycodone; systemic
2.6
7.7
57
244
Z02.7
ICD-10 Finland
Issue of medical certificate
3.8
7.7
32
92
V03AB30
ATC
NA
19.0
7.7
11
6
R4110
NOMESCO Finland
Physiotherapy
2.2
7.6
92
502
M04AA01
ATC
allopurinol; systemic
2.5
7.5
61
276
F10
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol
82.0
7.4
8
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
8.7
7.4
15
18
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
9.7
7.4
14
15
S06.0
ICD-10 Finland
Concussion
3.0
7.3
43
160
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
7.3
65
307
K29.2
ICD-10 Finland
Alcoholic gastritis
+∞
7.3
7
*
G72.8
ICD-10 Finland
Other specified myopathies
16.2
7.3
11
7
N06AX21
ATC
duloxetine; oral
3.1
7.3
40
140
N05AF03
ATC
chlorprothixene; systemic
6.3
7.2
18
30
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
20.6
7.2
10
5
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
7.2
54
233
SPAT1216
SPAT
Assessment of functional ability
2.6
7.1
56
247
A02BC02
ATC
pantoprazole; systemic
1.9
7.0
197
1483
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
7.0
40
146
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
7.0
56
251
X58
ICD-10 Finland
Exposure to other specified factors
2.6
7.0
53
230
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
7.0
6.9
16
24
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.9
6.9
21
45
M79.6
ICD-10 Finland
Pain in limb
2.0
6.8
109
663
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.9
6.8
27
75
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
41.0
6.8
8
*
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
5.0
6.7
20
42
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.1
6.7
37
131
JDB10
NOMESCO Finland
Percutaneous gastrostomy
12.6
6.6
11
9
N06AB06
ATC
sertraline; oral
3.2
6.6
34
116
N30.0
ICD-10 Finland
Acute cystitis
3.0
6.6
37
133
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
6.5
60
287
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.1
6.5
34
118
R27.0
ICD-10 Finland
Ataxia, unspecified
71.3
6.4
7
*
SPAT1240
SPAT
Therapeutic discussion
3.3
6.4
31
101
F61.0
ICD-10 Finland
Mixed personality disorders
11.4
6.3
11
10
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
11.4
6.3
11
10
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
11.4
6.3
11
10
K86.1
ICD-10 Finland
Other chronic pancreatitis
11.4
6.3
11
10
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
18.5
6.3
9
5
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.5
6.3
28
86
N05AX08
ATC
risperidone; systemic
3.2
6.3
32
109
S92
ICD-10 Finland
Fracture of foot, except ankle
+∞
6.3
6
*
E51.2
ICD-10 Finland
Wernicke encephalopathy
27.3
6.3
8
*
S82.6
ICD-10 Finland
Fracture of lateral malleolus
3.6
6.2
27
81
N03AX14
ATC
levetiracetam; systemic
7.9
6.2
13
17
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.7
6.2
25
71
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.7
6.2
25
71
A41.9
ICD-10 Finland
Sepsis, unspecified
4.6
6.2
20
46
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.7
6.2
42
170
S82.2
ICD-10 Finland
Fracture of shaft of tibia
12.9
6.1
10
8
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
8.9
6.1
12
14
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
6.1
62
313
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.8
6.1
24
67
N06AA12
ATC
doxepin; systemic
3.9
6.0
23
62
SPAT1254
SPAT
Administration of medicine
2.4
6.0
52
239
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
122
365
4.62
38.13
3.3
2.0
%
2.2
1.6
4.56
110
314
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
83
276
3.64
21.18
3.2
2.2
g/l
0.2
0.2
1.31
75
257
(3012095) Magnesium [Moles/volume] in Serum or Plasma
113
466
3.12
20.27
4.9
3.6
mmol/l
0.7
0.8
10.89
103
439
(3004588) Protein electrophoresis panel - Serum or Plasma
61
176
4.00
19.01
1.5
2.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
116
511
2.91
18.23
1.8
1.7
nmol/l
1094.9
1145.5
0.20
92
395
(3020630) Protein [Mass/volume] in Serum or Plasma
68
221
3.59
17.77
1.6
2.9
g/l
65.4
66.7
0.61
62
201
(3003458) Phosphate [Moles/volume] in Serum or Plasma
93
368
3.09
17.65
7.2
6.2
mmol/l
1.0
1.0
0.59
83
347
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
73
254
3.38
17.12
5.0
2.7
u/l
26.4
36.2
1.52
68
220
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
99
4.57
16.05
1.3
2.0
g/l
3.0
3.2
0.45
32
79
(3024561) Albumin [Mass/volume] in Serum or Plasma
196
1202
2.46
14.93
7.1
5.3
g/l
32.8
35.2
6.31
185
1127
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
105
4.30
14.88
1.3
2.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
105
4.30
14.88
1.3
2.0
g/l
7.4
7.4
0.01
33
81
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
105
4.30
14.88
1.3
2.0
g/l
4.0
3.8
0.50
32
77
(3006653) Thiamine [Moles/volume] in Blood
16
15
11.14
14.75
1.1
1.0
nmol/l
137.9
160.1
0.33
16
15
(3000991) Gas panel - Venous blood
66
237
3.21
14.58
13.5
9.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
68
249
3.16
14.53
6.8
3.9
mmol/l
1.7
1.8
0.12
61
193
(3012544) pH of Venous blood
70
261
3.11
14.51
6.6
4.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
185
1128
2.38
13.98
2.6
2.0
pmol/l
89.8
93.8
0.51
118
615
(3018418) pH of Serum or Plasma
142
772
2.43
13.91
5.2
4.4
ph
7.4
7.4
0.14
23
146
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
97
4.28
13.83
1.3
2.0
g/l
10.6
11.0
0.19
32
84
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
131
692
2.44
13.63
2.7
2.0
mg/l
3.2
3.1
0.02
117
602
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
36
90
4.35
13.46
1.4
2.1
g/l
0.2
1.2
1.42
31
81
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
193
1217
2.33
13.25
11.3
6.5
mmol/l
1.2
1.2
3.69
181
1103
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
35
88
4.31
12.98
1.3
1.9
g/l
36.3
37.4
0.35
30
73
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
30
73
4.41
11.58
1.7
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
92
443
2.47
11.45
2.7
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
79
354
2.60
11.44
2.3
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
198
1317
2.18
11.26
11.1
7.4
mmol/l
1.2
1.2
2.55
175
1114
(1761868) Lipid panel - Serum or Plasma
43
1030
0.33
10.91
3.2
3.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
75
335
2.58
10.89
2.1
1.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
149
896
2.17
10.87
4.1
2.6
u/l
98.0
58.2
0.63
140
842
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
220
2746
0.45
10.73
4.5
4.7
mmol/l
1.4
1.4
0.22
195
2526
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
30
78
4.12
10.63
1.8
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
63
261
2.73
10.61
1.9
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
95
484
2.33
10.31
2.1
1.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
80
388
2.38
9.66
15.4
7.3
mmol/l
103.4
104.0
0.44
80
379
(40758558) Short blood count panel - Blood
117
667
2.14
9.55
6.4
7.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
72
341
2.40
9.13
2.2
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
82
412
2.30
9.08
11.8
23.5
inr
1.1
1.3
—
6
50
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
149
949
2.00
8.87
2.3
2.2
nmol/l
70.1
73.4
0.57
129
834
(3000570) Elastase.pancreatic [Mass/mass] in Stool
29
85
3.63
8.70
1.7
1.6
ug/g
298.4
271.1
0.27
18
52
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
50
203
2.71
8.70
1.9
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
227
2754
0.49
8.66
4.4
4.7
mmol/l
4.1
4.5
6.66
201
2559
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
218
2680
0.49
8.64
4.1
4.2
mmol/l
1.4
1.3
0.42
189
2458
(3021960) Folate [Moles/volume] in Serum or Plasma
117
692
2.05
8.50
1.8
1.6
nmol/l
18.3
20.4
0.82
109
585
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
72
353
2.31
8.40
4.9
3.2
umol/l
13.1
10.0
0.41
63
314
(42870588) Differential panel, method unspecified - Blood
144
926
1.95
8.18
5.2
5.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
204
1477
1.93
8.08
10.4
7.2
umol/l
15.5
12.3
1.09
196
1411
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
38
139
2.95
8.01
2.0
1.5
g/l
1.7
1.5
0.27
33
121
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
42
163
2.80
7.95
8.6
8.0
mmol/l
24.4
24.7
0.19
42
163
(3003396) Base excess in Arterial blood by calculation
71
355
2.26
7.88
12.4
8.3
mmol/l
1.2
1.0
0.19
61
282
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
60
279
2.39
7.87
2.0
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
136
869
1.93
7.79
7.9
4.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
45
185
2.65
7.63
1.9
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
237
2805
0.50
7.49
4.8
5.2
mmol/l
2.3
2.7
7.19
215
2583
(3044640) Blood type and Crossmatch panel - Blood
139
908
1.89
7.35
3.7
2.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
267
3033
0.47
7.30
46.4
22.3
e12/l
4.1
4.5
23.15
262
2936
(3010813) Leukocytes [#/volume] in Blood
267
3033
0.47
7.30
46.4
22.4
e9/l
7.5
6.9
4.86
262
2934
(3007461) Platelets [#/volume] in Blood
267
3031
0.47
7.20
46.4
22.3
e9/l
241.5
236.9
0.42
262
2943
(3023410) Appearance of Cerebral spinal fluid
14
27
5.36
7.03
1.3
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
124
796
1.87
6.82
4.2
3.1
e6/l
0.8
0.6
0.24
91
601
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
17
6.65
6.81
1.5
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
141
946
1.83
6.71
5.5
3.7
u/l
46.9
35.1
2.66
130
895
(46235355) HIV 1 and 2 tests - Meaningful Use set
65
334
2.17
6.69
1.9
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
110
684
1.89
6.66
3.4
2.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
112
702
1.88
6.60
4.0
2.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
25
5.36
6.54
1.6
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
40
169
2.55
6.41
1.6
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
69
371
2.07
6.30
1.7
1.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
19
52
3.81
6.29
1.3
1.3
e6/l
47.9
2162.3
0.52
14
43
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
19
52
3.81
6.29
1.2
1.2
e6/l
2.9
21.2
0.75
14
42
(3026782) Osmolality of Urine
94
565
1.91
6.26
2.9
2.7
mosm/kgh2o
464.3
594.4
6.23
81
478
(36304419) Bacteria [Presence] in Urine
117
759
1.82
6.11
4.3
3.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
16
6.41
5.99
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
59
3.54
5.96
2.0
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
80
463
1.95
5.93
2.8
2.3
umol/l
10.9
13.1
1.80
75
433
(3000850) Epithelial cells [#/volume] in Urine
96
592
1.86
5.86
2.8
2.5
e6/l
5.9
3.7
1.09
81
515
(3033799) Differential panel - Peritoneal fluid
10
9
11.40
5.83
1.4
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
46
3.84
5.71
1.4
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
46
3.84
5.71
1.2
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
129
878
1.75
5.64
4.4
3.2
e6/l
23.1
138.0
0.94
97
690
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
65
358
2.00
5.53
2.2
4.0
u/l
276.6
247.6
0.21
59
337
(3027945) Reticulocytes/100 erythrocytes in Blood
65
359
2.00
5.48
2.5
2.5
%
2.0
1.9
0.30
57
331
(3014007) Fractional oxyhemoglobin in Arterial blood
41
190
2.31
5.39
18.3
10.1
%
92.8
94.4
0.85
41
190
(3032080) INR in Blood by Coagulation assay
167
1232
1.69
5.38
9.7
9.0
inr
1.2
1.3
0.48
35
341
(3028707) Methadone [Presence] in Urine by Screen method
11
22
5.13
5.29
2.3
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
80
482
1.86
5.20
2.8
3.3
mmol/l
2.5
2.4
0.24
65
424
(3006315) Basophils [#/volume] in Blood
179
1355
1.67
5.15
5.8
5.9
e9/l
0.0
0.0
0.01
147
1166
(3022096) Basophils/100 leukocytes in Blood
167
1244
1.66
5.10
6.1
6.0
%
0.7
0.7
0.03
155
1156
(3018095) Leukocytes [#/volume] in Urine
139
988
1.68
5.08
5.0
3.7
e6/l
129.6
63.8
0.71
98
735
(3001604) Monocytes [#/volume] in Blood
178
1349
1.66
5.07
5.9
5.9
e9/l
0.6
0.6
0.44
144
1153
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
80
486
1.84
5.06
3.9
2.9
e6/l
2.1
1.0
0.44
45
282
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
82
505
1.82
4.95
3.8
2.7
e6/l
1.0
1.0
0.00
46
296
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
51
3.45
4.95
1.9
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
51
3.45
4.95
1.9
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
169
1270
1.65
4.94
6.1
6.1
%
2.5
2.9
2.21
158
1179
(3019198) Lymphocytes [#/volume] in Blood
180
1376
1.64
4.90
5.9
5.9
e9/l
1.7
2.0
0.92
149
1207
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
25
96
2.73
4.84
2.1
3.4
—
1.2
—
0
12
(3039443) Prostate specific Ag panel - Serum or Plasma
0
122
0.00
4.82
0.0
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
20
5.12
4.80
1.1
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
37
173
2.28
4.77
4.1
4.2
ng/l
98.3
86.5
0.39
32
155
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
105
1468
0.59
4.76
3.4
4.3
%
19.3
21.1
0.59
42
704
(3019069) Monocytes/100 leukocytes in Blood
169
1281
1.63
4.69
6.5
6.4
%
8.9
8.9
0.01
158
1193
(3002030) Lymphocytes/100 leukocytes in Blood
171
1306
1.61
4.57
6.2
6.2
%
23.8
26.6
2.56
158
1210
(3020564) Creatinine [Moles/volume] in Serum or Plasma
262
2925
0.57
4.56
36.6
18.2
umol/l
85.4
83.8
0.15
262
2925
(3018010) Neutrophils/100 leukocytes in Blood
168
1280
1.61
4.51
6.1
6.0
%
61.2
57.6
2.81
157
1198
(3011288) Drugs identified in Urine by Screen method
13
35
3.82
4.40
2.6
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
19
66
2.99
4.40
1.4
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
143
1053
1.61
4.39
4.8
3.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
20
72
2.89
4.36
1.5
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
179
1393
1.59
4.35
6.5
6.2
e9/l
0.2
0.2
0.92
150
1226
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
9
9.07
4.30
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
16
51
3.24
4.26
1.4
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
263
2922
0.58
4.21
18.4
11.0
u/l
27.4
28.5
0.45
254
2819
(3013650) Neutrophils [#/volume] in Blood by Automated count
194
1546
1.58
4.20
8.8
10.1
e9/l
4.9
4.2
2.18
166
1350
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
37
183
2.14
4.17
2.1
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
55
315
1.89
4.15
1.4
1.3
titre
581.8
439.4
0.43
11
71
(3001122) Ferritin [Mass/volume] in Serum or Plasma
144
1074
1.58
4.13
3.4
2.5
ug/l
267.4
182.6
0.98
133
984
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
23
4.45
4.11
1.0
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
17
58
3.03
4.07
5.4
2.9
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
33
3.73
3.95
1.6
2.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
43
3.35
3.95
1.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
73
1080
0.59
3.92
2.7
3.1
ug/l
0.6
0.8
1.26
51
721
(3005719) IgG [Mass/volume] in Serum or Plasma
42
224
2.00
3.89
1.8
2.0
g/l
12.4
10.7
1.42
37
204
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
142
1798
0.64
3.88
4.1
4.9
ug/l
1.7
2.5
2.07
130
1613
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
102
2.45
3.83
3.4
2.4
u/ml
0.2
0.4
3.49
13
54
(3052851) Hemolysis interference index of Serum or Plasma
22
90
2.54
3.80
5.5
3.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
34
3.62
3.80
1.3
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
16
55
3.00
3.79
1.7
1.6
—
—
—
0
0
(4198724)
6
5
12.18
3.77
2.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
25
4.09
3.72
1.2
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
67
2.78
3.72
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
67
2.78
3.72
1.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
67
2.78
3.72
1.3
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
256
2844
0.61
3.66
28.9
14.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
72
467
1.68
3.56
1.7
1.3
g/l
3.8
2.9
2.18
51
290
(3004716) Salmonella sp identified in Stool by Organism specific culture
23
100
2.39
3.51
1.3
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
117
858
1.55
3.50
3.4
3.6
mmol/l
2.3
2.3
0.30
97
749
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
242
2716
0.63
3.49
5.0
4.8
mmol/l
6.3
6.1
1.00
217
2474
(3044941) Cell count panel - Synovial fluid
14
47
3.06
3.45
1.7
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
20
82
2.53
3.45
2.0
1.5
%
82.5
85.2
0.19
20
77
(3011397) Hemoglobin [Presence] in Urine by Test strip
87
600
1.60
3.38
3.5
3.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
83
2.50
3.37
1.3
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
59
2.80
3.37
1.5
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
27
129
2.19
3.34
8.3
2.5
%
0.6
0.7
0.38
27
124
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
39
215
1.92
3.30
4.5
2.7
ml/min/173m2
71.2
66.0
0.15
13
82
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
20
84
2.47
3.29
1.0
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
233
2625
0.65
3.25
29.5
14.1
ml/min/173m2
84.0
78.8
2.38
200
2194
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
41
236
1.84
3.05
4.1
3.0
ng/l
280.3
181.5
0.53
34
213
(40767503) Oxygen content in Capillary blood by calculation
14
51
2.82
3.02
3.3
2.6
%
15.7
16.3
—
8
24
(4281824)
9
21
4.37
3.01
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
78
0.00
2.99
0.0
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
14
53
2.71
2.83
3.4
2.7
g/l
128.3
130.3
—
8
38
(1616796) Gas panel - Central venous blood
14
53
2.71
2.83
4.1
4.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
216
1848
1.45
2.80
8.0
3.4
u/l
107.7
58.4
5.82
205
1725
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
23
3.99
2.79
1.2
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
83
592
1.53
2.74
1.7
1.7
pmol/l
85714783.1
8130484.1
0.43
70
492
(3023103) Potassium [Moles/volume] in Serum or Plasma
265
2884
0.65
2.74
40.5
18.0
mmol/l
4.0
4.0
0.87
258
2808
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
78
550
1.54
2.71
4.7
4.0
ng/l
78.6
349.3
2.23
70
456
(40760888) Immunoglobulin light chains.free panel - Serum
16
67
2.46
2.67
2.4
4.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
236
2623
0.68
2.66
7.0
6.2
mmol/mol
39.7
40.7
0.70
220
2434
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
18
80
2.32
2.65
3.5
2.5
mg/l
1.7
1.6
0.19
18
72
(3023520) Reticulocytes [#/volume] in Blood
44
271
1.71
2.63
2.2
2.7
e9/l
83.3
73.9
0.47
28
215
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
24
122
2.04
2.57
1.6
3.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
11
5.53
2.55
1.0
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
26
3.53
2.50
1.2
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
26
3.53
2.50
1.9
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
265
2872
0.67
2.48
41.0
17.9
mmol/l
138.0
139.7
11.17
258
2794
(3013826) Glucose [Moles/volume] in Serum or Plasma
199
1699
1.40
2.47
10.5
5.1
mmol/l
6.9
6.9
0.09
191
1600
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
17
77
2.27
2.41
2.0
1.6
%
229.5
193.4
0.80
17
72
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
12
5.07
2.41
3.0
2.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
17
4.18
2.37
1.6
2.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
156
0.31
2.34
1.0
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
30
171
1.83
2.33
14.3
10.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
35
210
1.74
2.30
4.7
3.2
mmol/l
2.3
2.0
0.19
29
159
(4027681)
6
13
4.68
2.28
1.5
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
13
4.68
2.28
3.0
2.9
%
88.0
96.6
—
6
13
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
73
2.25
2.24
1.4
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
240
2138
1.40
2.19
12.8
8.2
u/l
91.8
79.8
3.90
228
2002
(3025941) Bacteria identified in Stool by Culture
26
145
1.86
2.17
1.3
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
14
4.34
2.16
1.7
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
14
4.34
2.16
1.7
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
14
4.34
2.16
1.3
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
43
2.61
2.11
1.3
2.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
25
3.25
2.10
1.0
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
36
224
1.68
2.10
4.6
3.1
ph
7.4
7.4
—
7
18
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
10
5.05
2.07
1.0
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
12
50
2.45
2.05
6.2
2.3
%
61.2
65.4
0.26
12
50
(3016879) Cocaine [Presence] in Urine
12
50
2.45
2.05
2.3
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
15
4.05
2.04
1.7
1.7
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
6
15
4.05
2.04
2.7
1.6
u/l
2.8
10.1
—
6
8
(3000494) Fungus identified in Specimen by Culture
52
357
1.54
2.04
1.3
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
32
2.86
2.01
2.3
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
46
309
1.56
1.99
4.9
3.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
51
2.40
1.97
2.3
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
53
737
0.67
1.96
4.5
3.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
54
747
0.67
1.95
1.4
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
52
2.35
1.90
2.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
52
2.35
1.90
2.3
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
221
2437
0.74
1.88
37.4
16.5
%
37.0
40.3
6.25
151
1710
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
40
2.54
1.85
1.2
2.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
80
2.05
1.83
1.7
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
81
1031
0.72
1.82
5.3
3.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
143
1200
1.33
1.80
11.4
9.9
e9/l
0.0
0.0
0.42
115
978
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
117
1.85
1.78
1.7
2.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
77
588
1.40
1.77
1.9
1.6
mg/l
1.2
1.4
0.64
61
472
(3047189) Immunofixation for 24 hour Urine
5
13
3.89
1.72
1.0
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
40
272
1.53
1.66
2.4
2.4
ug/l
5.1
9.7
1.31
34
242
(3037467) Urinalysis macro (dipstick) panel - Urine
208
1854
1.31
1.64
5.0
4.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
64
480
1.41
1.63
1.3
1.2
u/ml
4.3
1.1
0.96
17
143
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
43
2.37
1.61
2.2
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
26
2.73
1.59
1.4
3.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
19
107
1.82
1.58
1.5
1.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
15
3.37
1.53
1.8
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
51
2.19
1.52
2.5
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
58
2.11
1.51
6.7
2.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
59
2.07
1.45
1.2
1.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
16
3.15
1.44
1.4
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
29
2.44
1.40
1.3
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
25
160
1.61
1.36
1.2
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
24
2.53
1.31
1.3
3.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
148
1290
1.26
1.29
4.9
4.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
35
2.32
1.27
5.4
3.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
19
2.65
1.22
3.0
1.4
g/l
1.0
1.0
—
5
19
(40768800) Prostate Pathology biopsy report
6
126
0.47
1.19
1.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
26
2.33
1.19
6.3
3.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
30
208
1.48
1.17
4.0
3.6
mmol/l
1.2
1.2
2.20
25
188
(3026493) Urate [Moles/volume] in Serum or Plasma
96
804
1.27
1.16
2.9
2.8
umol/l
384.2
6168.1
2.69
79
694
(3035880) pH of Pleural fluid
5
20
2.52
1.15
1.4
1.2
—
—
—
0
0
(3019225) pH of Specimen
37
269
1.42
1.14
4.6
4.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
30
2.36
1.13
1.6
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
26
177
1.51
1.11
4.3
3.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
21
136
1.58
1.11
8.6
3.8
mmol/l
26.4
24.9
0.91
21
131
(40768441) Liver Pathology biopsy report
5
21
2.40
1.09
2.4
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
7
33
2.14
1.06
1.3
1.4
u/l
133.3
297.2
—
7
33
(3027315) Oxygen [Partial pressure] in Blood
11
60
1.86
1.04
3.7
5.9
kpa
7.6
8.3
1.16
11
60
(3013290) Carbon dioxide [Partial pressure] in Blood
11
60
1.86
1.04
3.7
5.9
kpa
4.7
5.0
0.74
11
60
(3020891) Body temperature
17
108
1.60
0.98
23.0
4.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
23
2.19
0.98
1.2
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
29
208
1.43
0.98
9.8
5.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
1.3
—
65.8
—
0
10
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
36
1.96
0.97
1.3
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
36
1.96
0.97
1.3
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
36
1.96
0.97
1.3
1.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
50
1.82
0.97
1.7
3.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
25
344
0.71
0.90
3.0
2.1
nmol/l
14.2
13.7
0.09
20
303
(3045414) Leukocytes [Presence] in Urine
17
111
1.56
0.89
1.5
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
31
230
1.38
0.88
3.4
4.4
%
0.1
0.2
0.31
12
79
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
106
925
1.21
0.87
2.7
3.1
ng/l
2959.0
1229.3
1.01
93
795
(3045424) Erythrocytes [Presence] in Urine
8
44
1.84
0.86
1.5
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
45
1.80
0.85
1.9
3.6
—
636.6
—
0
8
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
21
146
1.47
0.84
3.5
3.5
mmol/l
25.0
25.3
0.25
21
135
(3015171) Extractable nuclear Ab [Units/volume] in Serum
12
73
1.67
0.82
1.2
1.3
—
3.6
—
0
5
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
89
1.60
0.82
1.5
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
32
1.89
0.82
1.3
1.8
%
87.3
89.8
—
6
32
(3002179) Metamyelocytes/100 leukocytes in Blood
29
216
1.37
0.82
3.2
4.4
%
0.7
0.4
0.77
12
64
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
64
759
0.81
0.80
1.5
1.7
mmol/l
1.3
1.4
0.92
56
636
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
17
115
1.50
0.78
1.3
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
83
1.59
0.76
1.8
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
105
927
1.19
0.76
3.3
3.1
mmol/l
6.6
8.3
3.85
84
763
(3044889) 12 lead EKG panel
186
1996
0.85
0.76
4.3
4.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
310
0.72
0.75
1.5
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
24
2.10
0.75
1.4
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(4062490)
5
25
2.01
0.73
1.4
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
56
1.62
0.73
1.4
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
84
1.57
0.73
1.2
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
57
1.59
0.71
1.4
2.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
32
249
1.31
0.70
3.3
4.3
%
1.2
0.9
0.36
13
89
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
41
1.72
0.70
1.3
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
85
1.55
0.70
1.2
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
101
896
1.18
0.69
3.4
3.3
mg/l
698.3
200.6
0.36
70
613
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
42
1.68
0.69
1.3
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
42
1.68
0.69
1.3
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
42
1.68
0.69
1.3
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
43
1.64
0.67
1.3
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
43
1.64
0.67
1.3
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
211
1988
1.16
0.65
4.6
4.1
mm/h
20.7
12.6
5.49
190
1832
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
49
1.65
0.62
1.3
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
30
1.68
0.61
1.6
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
197
1852
1.15
0.61
3.2
3.4
pmol/l
14.6
14.9
0.63
182
1651
(3017569) Oxygen content in Arterial blood
0
20
0.00
0.60
0.0
4.8
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.3
—
0.4
—
0
13
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.1
—
6.0
—
0
5
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
0.4
—
0
5
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
27
212
1.30
0.57
3.6
4.6
%
3.2
0.1
0.45
12
69
(3013512) EKG study
79
887
0.86
0.55
4.7
4.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
28
224
1.27
0.53
3.8
3.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
64
1.42
0.52
1.7
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
64
1.42
0.52
1.7
1.5
—
—
—
0
0
(4306422)
6
40
1.51
0.52
1.0
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
263
2715
0.87
0.49
35.2
15.3
mg/l
30.8
26.2
1.48
242
2203
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
45
1.57
0.49
2.0
3.0
%
60.6
57.5
—
7
45
(44790047)
7
46
1.53
0.48
1.1
1.6
—
—
—
0
0
(44806118)
7
46
1.53
0.48
1.1
1.6
—
—
—
0
0
(44790049)
7
46
1.53
0.48
1.1
1.6
—
—
—
0
0
(44790048)
7
46
1.53
0.48
1.1
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
47
1.50
0.48
1.1
4.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
45
386
1.19
0.46
1.3
1.3
iu/ml
40.3
36.1
—
8
122
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
8
121
0.65
0.46
1.3
1.6
nmol/l
36.8
42.5
—
8
115
(1761482) Bacteria [#/volume] in Urine by Culture
5
84
0.59
0.46
7.6
3.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
27
220
1.25
0.45
5.8
3.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
50
1.41
0.45
1.1
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
16
121
1.34
0.45
1.3
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
31
1.62
0.43
1.2
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
6
92
0.65
0.43
3.7
8.5
mmol/l
1.7
1.4
—
6
80
(3032773) Endomysium IgG Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
15
0.00
0.41
0.0
2.0
—
13.1
—
0
15
(3037556) Urate [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
33
388
0.83
0.41
4.2
4.7
%
29.9
30.9
0.14
21
271
(3025130) Human papilloma virus identified in Specimen
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
10
137
0.72
0.40
1.1
1.3
u/ml
288.7
206.0
—
10
123
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
8
61
1.32
0.40
1.3
1.2
u/ml
259.1
271.5
—
8
37
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
71
1.42
0.39
1.3
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.0
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
68
1.33
0.38
1.2
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
37
1.36
0.37
1.2
1.1
—
—
—
0
0
(4035726)
28
236
1.20
0.36
1.3
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
42
1.44
0.35
1.8
2.9
e9/l
4.4
5.0
—
6
42
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
41
360
1.16
0.34
1.4
1.3
u/ml
5.1
15.7
—
8
126
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
6
86
0.69
0.33
1.2
1.8
pmol/l
159.8
229.5
—
6
79
(3027456) Digoxin [Moles/volume] in Serum or Plasma
7
53
1.33
0.31
5.3
2.5
nmol/l
0.8
0.9
—
7
38
(40760892) CBC W Ordered Manual Differential panel - Blood
52
574
0.89
0.30
4.2
5.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
63
1.28
0.28
1.1
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
137
1305
1.08
0.28
5.6
4.6
estimate
0.0
0.0
0.00
25
251
(3000492) Spirometry study
32
281
1.15
0.27
1.6
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
137
1311
1.07
0.24
4.2
3.4
estimate
0.0
0.0
0.00
25
246
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
152
1.19
0.24
1.6
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
123
1173
1.08
0.24
4.8
3.9
ng/l
32.6
50.7
0.82
103
871
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
5
38
1.32
0.23
2.2
1.7
%
78.0
61.3
—
5
32
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
39
1.29
0.23
2.6
3.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
353
1.12
0.23
14.5
7.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
156
0.83
0.21
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
6.9
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(44813793)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
29
324
0.89
0.21
1.2
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
136
1.19
0.20
1.6
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(4211845)
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
9
115
0.78
0.20
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
138
1330
1.06
0.19
4.2
3.4
estimate
0.0
0.0
0.50
24
233
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
1.2
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
51
1.18
0.19
1.3
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
12
100
1.21
0.18
3.5
3.8
g/l
0.2
0.2
—
5
46
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
68
1.18
0.16
1.1
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
36
332
1.09
0.16
1.4
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
73
1.10
0.16
3.5
2.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
79
1.14
0.15
1.1
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
99
953
1.05
0.14
4.2
4.0
mg/mmol
8.5
8.5
0.00
64
625
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
132
1.14
0.13
3.6
2.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
54
568
0.94
0.12
5.1
3.7
kg/l
1.0
1.0
—
8
87
(3022621) pH of Urine by Test strip
17
189
0.89
0.12
2.4
2.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
11
126
0.87
0.11
1.1
1.2
iu/ml
241.1
129.7
—
5
43
(3049717) Cytology report of Urine Cyto stain
17
153
1.12
0.11
2.5
2.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
21
192
1.10
0.11
25.3
7.6
mmol/l
26.3
24.1
2.16
21
179
(3000330) Specific gravity of Urine by Test strip
13
146
0.89
0.10
4.5
3.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
48
1.04
0.09
1.2
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
55
1.09
0.09
1.2
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
57
1.05
0.08
1.0
1.1
—
4.0
—
0
6
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
58
1.04
0.08
1.5
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
74
1.08
0.07
1.6
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
7
83
0.84
0.07
3.7
2.1
mg/l
15.5
13.2
—
7
77
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
14
130
1.08
0.04
2.9
6.4
%
1.5
1.6
0.23
14
121
(3013139) Helicobacter pylori Ag [Presence] in Stool
16
150
1.07
0.04
1.1
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
37
358
1.04
0.04
1.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
104
1053
0.98
0.03
2.2
2.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
239
2377
1.02
0.03
4.5
4.1
mu/l
2.0
2.0
0.35
226
2127
(3048689) Calprotectin [Mass/mass] in Stool
27
278
0.97
0.02
1.8
2.2
ug/g
118.8
130.3
0.15
21
237
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
103
1.07
0.02
1.1
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
72
727
0.99
0.01
4.9
3.5
estimate
0.0
0.0
0.50
22
231
(4034850)
10
94
1.07
0.01
21.6
12.8
—
—
—
0
0
(4010399)
22
219
1.00
0.00
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
149
1485
1.01
0.00
2.8
2.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
13
130
1.00
0.00
3.0
6.5
%
0.8
0.9
0.41
13
122
(21494814) CD8 cells/100 lymphocytes in Specimen
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
2.5
—
12527.0
—
0
6
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.0
—
104.2
—
0
5
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
4.6
—
11.6
—
0
8
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
8.8
—
0
9
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
133.7
—
0
7
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
51
0.98
0.00
1.6
2.7
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
8
0.00
0.00
0.0
8.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
64
0.94
0.00
1.3
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.2
—
111.5
—
0
6
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_ALCOPOLY and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_ALCOPOLY | 6.471 [5.09, 8.24] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.275 |
During the follow-up period (1.1.1998 — 31.12.2019), 255 out of 596 females with G6_ALCOPOLY died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_ALCOPOLY | 5.295 [4.65, 6.04] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1346 out of 2491 males with G6_ALCOPOLY died.
Mortality risk
Mortality risk for people of age
years, who have G6_ALCOPOLY.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.432% | 0.871% |
| 5 | 3.556% | 5.907% |
| 10 | 9.79% | 13.436% |
| 15 | 17.855% | 24.306% |
| 20 | 29.641% | 37.061% |
Relationships between endpoints
↥Index endpoint: G6_ALCOPOLY – Alcohol induced polyneuropathy
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data